From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights

From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights

Although most same-stage non-alcoholic fatty liver disease (NAFLD) patients exhibit similar histologic sequelae, the underlying mechanisms appear to be highly heterogeneous. Therefore, it was recently proposed to redefine NAFLD to metabolic dysfunction-associated fatty liver disease (MAFLD) in which...

Full description

Bibliographic Details
Main Authors: Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, Joery De Kock, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke, Joost Boeckmans
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Biomedicines
Subjects:
NAFLD
MAFLD
NASH
liver
drug development
pharmacology
Online Access:https://www.mdpi.com/2227-9059/10/1/161

Internet

https://www.mdpi.com/2227-9059/10/1/161

Similar Items